• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Blog
  • News & Events
  • Videos
  • Resources
main-logo-small

Compliance Architects

Consulting Technology Outsourcing

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Compliance Architects® Proud to Sponsor and Moderate at This Year’s FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law – May 18–20, 2021 | Virtual Event

Compliance Architects® is particularly excited to announce CEO Jack Garvey’s participation in this year’s event as Moderator of, “Medical Product Facility Inspections and COVID-19: What is the Latest, and What Can Industry Expect Moving Forward?“ This engaging session is scheduled for Day 2 of the event starting at 1:30pm Eastern. Jack will be joined by…

Kalah Auchincloss, Executive Vice President and Deputy General Counsel, Greenleaf Health, Inc.

Elizabeth Miller, Assistant Commissioner for Medical Products and Tobacco, ORA, FDA

Vipul Sheth, Vice President, Quality and Regulatory Compliance, Becton, Dickinson and Company (BD)

Moderated by John (Jack) C. Garvey, Managing Partner, Compliance Architects LLC

In March 2020, FDA temporarily postponed all domestic and foreign routine surveillance facility inspections (excepting mission-critical inspections) because of the COVID-19 outbreak. Since, FDA has been utilizing its authority under 704(a)(4) to request and review records and resume prioritized domestic inspections. In April 2021, FDA released guidance on remote interactive evaluations (REIs). This session will delve into how and when REI’s will be used, what it means for companies, and areas of risk. Speakers will also address what new COVID-driven inspection practices may continue post-pandemic.

FDLI is excited to provide the key industry updates and the opportunity to connect with the food and drug law community that you have come to expect from the Annual Conference in a virtual format. While we will miss seeing each other in person, a virtual format allows the whole food and drug law community to participate regardless of safety concerns, location, time zone, or budget constraints. The Annual Conference will host an array of experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, and academia over the span of three shortened days to address the latest trends and updates in complex legal, regulatory, compliance, and policy issues currently impacting all facets of FDA-regulated industry.

Additional Conference Highlights:

  • Hear FDA’s strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors, and other key leaders within the Agency and the impacts of COVID-19 as we move through 2021
  • Gain in-depth knowledge of each FDA Center by attending consecutive Center Director sessions scheduled to maximize attendee participation
  • Join high-level colleagues in food and drug law to hear different viewpoints, shape policy, and advance understanding in the post-COVID era
  • Select from over 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing, and related issues
  • Learn from more than 100 well-known officials and experts
  • Hear about the Top Cases in Food and Drug Law
  • Network and build relationships with seasoned legal, regulatory, compliance, policy, and government professionals

Key FDA Speakers:

  • Janet Woodcock, Acting Commissioner, FDA
  • Mark Raza, Acting Chief Counsel, FDA
  • Patrizia Cavazzoni, Acting Director, Center for Drug Evaluation and Research, FDA
  • Peter W. Marks, Director, Center for Biologics Evaluation and Research, FDA
  • Susan T. Mayne, Director, Center for Food Safety and Applied Nutrition, FDA
  • Jeffrey E. Shuren, Director, Center for Devices and Radiological Health, FDA
  • Steven M. Solomon, Director, Center for Veterinary Medicine, FDA
  • Mitchell R. Zeller, Director, Center for Tobacco Products, FDA

Primary Sidebar

Sign Up To Our Newsletter

Related Events

Proud to be a Silver Sponsor of RIC’s inaugural annual meeting! Join us March 22-23, 2023 at Convene in Arlington, VA!

Compliance Architects is proud to be Silver Sponsor of this year's RIC's inaugural annual meeting! The REMS Industry Consortium fosters collaboration and innovation to advance

1st Annual Digital CMC Summit Hosted by QbDVision – Austin, TX – November 2-4, 2022 – Jack Garvey to Serve as Featured Speaker

The Future of High-Performance Drug Development is Here Join Us In-Person for the 1st Annual Digital CMC Summit! Compliance Architects® is proud to announce that

Jack Garvey and Judy Carmody to Speak at AGXPE Fall Mid-Atlantic Chapter Meeting (In-person) – September 16th, 2022

The Association for GXP Excellence (AGXPE) will hold a live Mid-Atlantic Chapter meeting at the home facility of one of their sponsors, Red Nucleus (19 W College

Footer

Compliance Architects®

  • Contact Us
  • (888) 734-9778
  • info@compliancearchitects.com

Quick Links

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Our Services

  • Inspection Readiness & Enforcement
  • FDA Quality Consulting – Systems and Training
  • Quality Assurance and Engineering
  • Corporate Compliance and Litigation Services
  • FDA Regulatory Consultants – Due Diligence
  • Quality, Compliance, Regulatory & Operations’ Staffing Services

Proprietary Solutions

  • Writing for Compliance®
  • Quality Pulse®
  • CRPN Quality Roadmap®

© 2009-2023 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.

  • Debarment Certification Statement
  • Privacy Policy
  • Terms of Use

Contact Us Today

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT